Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

ARTV US Equity

Artiva Biotherapeutics, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1817241 · FY ends Dec 31
$11.70
+0.02 (+0.17%)
USD · as of 2026-08-19 · marketstack
2 8-K filings · 1 13D · 2 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Venrock Healthcare Capital Partners III, L.P.sec.gov ↗
2026-08-1013G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by 5AM Ventures VI, L.P.sec.gov ↗
2026-08-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-2413D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by RA CAPITAL MANAGEMENT, L.P.sec.gov ↗
2026-07-228-K 8.01Other eventssec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-22

Every row is a filed document, checked against its EDGAR index.